To ask the Secretary of State for Health and Social Care, with reference to a recent research paper entitled Probiotic improves symptomatic and viral clearance in covid-19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial, what assessment he has made of the implications for his policies of the findings of that research that probiotics improve symptomatic and viral clearance in covid-19 outpatients.
This answer is the replacement for a previous holding answer.
31 January 2022
No formal assessment has been made. However, the Therapeutics Taskforce is monitoring data from clinical trials taking place worldwide to identify safe and effective treatments for COVID-19. The Taskforce works closely with RAPID C-19, a multi-agency group from across the health system, to review and evaluate evidence on the effectiveness of promising COVID-19 treatments when clinical trial data becomes available.